Secukinumab provides clearer skin and better control on patient-reported psoriasis symptoms of itching, pain, and scaling than placebo and etanercept

Strober, B., Sigurgeirsson, B., Popp, G., Sinclair, R., Krell, J., & Mordin, M. (2016). Secukinumab provides clearer skin and better control on patient-reported psoriasis symptoms of itching, pain, and scaling than placebo and etanercept. Journal of Psoriasis and Psoriatic Arthritis , 1(4), 167-175.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Development of a novel shared decision making aid for primary immunodeficiency diseases
Article

Community overdose surveillance
Article

Epigenetic biomarkers for smoking cessation